|
 |
Cancer > Xenograft
The following information is about Xenograft.
Xenograft Defined
The cells of one species transplanted to another species.
This definition is in context to Cancer. See more contextual defintions for Xenograft.
Curis Announces Nature Publication Elucidating a Paracrine Mechanism of Action in Hedgehog-Expressing Tumors
Published August 27, 2008, 10:29 am, Centre Daily Times
Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing next generation proprietary targeted medicines for cancer treatment, today announced the publication of preclinical data in Nature that support the premise that Hedgehog proteins play an important role in supporting tumor growth in Hedgehog-expressing solid tumors through a paracrine mechanism of action.
Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors
Published August 26, 2008, 12:55 pm, PR Newswire via Yahoo! Finance
Semafore Pharmaceuticals Inc. presented data at the Seventh International Congress on Targeted Therapies in Cancer in Washington, D.C., announcing the discovery of novel multi-targeted kinase inhibitors that demonstrate significant anticancer activity in preclinical studies.
SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell ...
Published August 26, 2008, 12:48 pm, PR Newswire via Yahoo! Finance
Semafore Pharmaceuticals Inc. announced data presented at the Seventh International Congress on Targeted Therapies in Cancer in Washington, D.C., showing additional antiangiogenic activity of vascular-targeted PI3 kinase inhibitor SF1126, by blocking both VEGF and Bv8 signaling.
Novosom AG Acquires Exclusive License from Isis Pharmaceuticals, Inc. for CD40-Targeted Antisense Inhibitors
Published August 26, 2008, 8:29 am, Centre Daily Times
Novosom AG today announced that it has acquired an exclusive, worldwide license from Isis Pharmaceuticals to access certain antisense inhibitors targeting CD40 mRNA for a number of indications. This deal exercises an option agreement signed in February 2007 between the two companies and provides Novosom AG with exclusive, worldwide and sub-licensable access to certain of Isis' proprietary ...
Novosom AG Acquires Exclusive License from Isis Pharmaceuticals, Inc. for CD40-Targeted Antisense Inhibitors
Published August 26, 2008, 12:30 am, Business Wire via Yahoo! Finance
HALLE, Germany----Novosom AG today announced that it has acquired an exclusive, worldwide license from Isis Pharmaceuticals to access certain antisense inhibitors targeting CD40 mRNA for a number of indications.
Are you looking for additional Cancer > Xenograft news? Try our new "Xenograft News Focus" area.
Off-site Xenograft Links, User Submitted
The following links have been collected through user bookmark submission in the Xenograft category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Thu Nov 30
- Animal tissues including bovine pericardium from BSE free New Zealand for medical & pharmaceutical uses.: Information regarding the availability and use of animal tissues to aid humans. Bovine pericardium for xenografts including heart & vascular repair and urology.
Wed Aug 2
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Xenograft. If you would like to find related tags we recommend Tag Patterns > Xenograft
Off-site Xenograft Research Links
If you still need additional information on Xenograft then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Cancer Topics
Everything you need to know about Cancer
Cancer
If you know the Cancer Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Cancer.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.